NC
USNA icon

NewSquare Capital’s Usana Health Sciences USNA Stock Holding History

NewSquare Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$305 – 1181
2025
Q2 		$305 Buy
+10
New +$284 ﹤0.01% 1194

Other funds holding USNA

SWGC
Summit Wealth Group (Colorado) Colorado Springs, Colorado $950M AUM 24.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

NewSquare Capital's USNA Position: Q3 2025 in Review

NewSquare Capital sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 10 shares — an estimated $305 sold.

NewSquare Capital first reported a position in USNA in Q2 2025 and held it in 1 quarter. The position peaked at $305 in Q2 2025. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

  • NewSquare Capital reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 10 Usana Health Sciences shares in Q3 2025, an estimated $305.
  • NewSquare Capital first reported a position in Usana Health Sciences in Q2 2025 and held it in 1 quarter.
  • NewSquare Capital's Usana Health Sciences position peaked at $305 in Q2 2025.
  • 165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.